NI694868 AVICEDA GLYCOTECH LTD false 2023-02-24 2024-02-28 2024-02-28 false The principal activity of the company is research and experimental development on biotechnology NI694868 uk-bus:PrivateLimitedCompanyLtd 2023-02-24 2024-02-28 NI694868 2023-02-24 2024-02-28 NI694868 uk-bus:RegisteredOffice 2023-02-24 2024-02-28 NI694868 uk-bus:Micro-entities 2023-02-24 2024-02-28 NI694868 uk-bus:FullAccounts 2023-02-24 2024-02-28 NI694868 uk-bus:AuditExempt-NoAccountantsReport 2023-02-24 2024-02-28 NI694868 2024-02-28 NI694868 uk-core:WithinOneYear 2024-02-28 NI694868 uk-core:AfterOneYear 2024-02-28 NI694868 uk-bus:Director1 2023-02-24 2024-02-28 NI694868 uk-bus:Director1 2024-02-28 iso4217:GBP shares pure
Registered number: NI694868
AVICEDA GLYCOTECH LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 28 FEBRUARY 2024
PAGES FOR FILING WITH REGISTRAR
AVICEDA GLYCOTECH LTD

BALANCE SHEET
AS AT 28 FEBRUARY 2024
2024
£
Current assets 49,994
Creditors: amounts falling due within one year (50,000)
Net current assets / (liabilities) (6)
Total assets less current liabilities (6)
Net assets / (net liabilities) (6)
Capital and reserves (6)

Notes to the financial statements:

  1. Average number of employees

    During the period the average number of employees, including directors, was 1.

AVICEDA GLYCOTECH LTD (NI694868) is a private company limited by shares incorporated in Northern Ireland. The registered office address is 63, University Road, Belfast, BT7 1NF, Northern Ireland.

For the period ending 28 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit of its financial statements for the period ended 28 February 2024 in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with micro-entity provisions and with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies' regime. The income statement has not been delivered to the Registrar of Companies in accordance with the special provisions applicable to companies subject to the small companies' regime.

The financial statements were approved by the board of directors and authorised for issue on 14 February 2025  and are signed on its behalf by:

Derek KUNIMOTO
Director
Company registration number: NI694868